Patents by Inventor Vincent P. Mauro
Vincent P. Mauro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230183299Abstract: The present disclosure provides materials and methods for cell-free expression of epitopes for immunotherapy applications. In particular, the present disclosure provides materials and methods for expressing concatenated epitopes using a cell-free protein synthesis platform for high throughput, large scale, and unbiased epitope screening and the generation of multi-epitope vaccines.Type: ApplicationFiled: February 22, 2023Publication date: June 15, 2023Applicant: Leidos, Inc.Inventors: Stephen A. Chappell, Vincent P. Mauro, John Dresios
-
Patent number: 11608363Abstract: The present disclosure provides materials and methods for cell-free expression of epitopes for immunotherapy applications. In particular, the present disclosure provides materials and methods for expressing concatenated epitopes using a cell-free protein synthesis platform for high throughput, large scale, and unbiased epitope screening and the generation of multi-epitope vaccines.Type: GrantFiled: July 1, 2019Date of Patent: March 21, 2023Assignee: Leidos, IncInventors: Stephen A. Chappell, Vincent P. Mauro, John Dresios
-
Publication number: 20200010512Abstract: The present disclosure provides materials and methods for cell-free expression of epitopes for immunotherapy applications. In particular, the present disclosure provides materials and methods for expressing concatenated epitopes using a cell-free protein synthesis platform for high throughput, large scale, and unbiased epitope screening and the generation of multi-epitope vaccines.Type: ApplicationFiled: July 1, 2019Publication date: January 9, 2020Applicant: Leidos, Inc.Inventors: Stephen A. Chappell, Vincent P. Mauro, John Dresios
-
Patent number: 10017786Abstract: Provided herein are methods for stable integration and/or expression of one or more recombinant polynucleotides in a host cell. The recombinant polynucleotides are typically integrated into the host genome at some native chromosomal integration sites. The integration can be mediated by homologous recombination or by using a hybrid recombinase targeting the specific chromosomal locations. The native chromosomal integration sites in the host cells, which support stable integration and strong transcription activities of foreign genes, are present within or adjacent to specific genes in the CHO genome, the ankyrin 2 gene (Ank2), cleavage and polydenylation specific factor 4 gene (Cpsf4), C-Mos gene, and Nephrocystin-1/Mal gene. Also provided are methods and nucleic acid molecules for inserting site-specific recombination sequences (chromosomal landing pads) into these specific chromosomal locations, engineered host cells containing chromosomal landing pads, methods and compositions (e.g., kits) therefore.Type: GrantFiled: February 12, 2015Date of Patent: July 10, 2018Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Wei Zhou, Bruce Cunningham, Gerald M. Edelman
-
Patent number: 9493768Abstract: A translation enhancer-driven positive feedback vector system is disclosed which is designed to facilitate identification of a Translational Enhancer Element (TEE) and to provide a means for overexpression of gene products. The system exploits both transcriptional and translational approaches to control the expression levels of genes and/or gene products. Methods are also disclosed for screening libraries of random nucleotide sequences to identify translational elements and for overproduction of proteins, which have uses in both research and industrial environments.Type: GrantFiled: May 18, 2015Date of Patent: November 15, 2016Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Patent number: 9359616Abstract: Provided herein is a synthetic or isolated polynucleotide encoding a mammalian 18S rRNA that is resistant to pactamycin. The pactamycin-resistance is conferred by one or more single residue substitutions in the 18S rRNA sequence; a fragment thereof harboring said substitutions; a complementary sequence thereto; or a substantially identical sequence of the foregoing. Related systems, methods and kits are also described.Type: GrantFiled: May 21, 2013Date of Patent: June 7, 2016Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Luke Burman, Gerald M. Edelman
-
Publication number: 20150267190Abstract: A translation enhancer-driven positive feedback vector system is disclosed which is designed to facilitate identification of a Translational Enhancer Element (TEE) and to provide a means for overexpression of gene products. The system exploits both transcriptional and translational approaches to control the expression levels of genes and/or gene products. Methods are also disclosed for screening libraries of random nucleotide sequences to identify translational elements and for overproduction of proteins, which have uses in both research and industrial environments.Type: ApplicationFiled: May 18, 2015Publication date: September 24, 2015Inventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Patent number: 9074220Abstract: A translation enhancer-driven positive feedback vector system is disclosed which is designed to facilitate identification of a Translational Enhancer Element (TEE) and to provide a means for overexpression of gene products. The system exploits both transcriptional and translational approaches to control the expression levels of genes and/or gene products. Methods are also disclosed for screening libraries of random nucleotide sequences to identify translational elements and for overproduction of proteins, which have uses in both research and industrial environments.Type: GrantFiled: August 16, 2010Date of Patent: July 7, 2015Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Patent number: 9068197Abstract: A translation enhancer-driven positive feedback vector system is disclosed which is designed to facilitate identification of a Translational Enhancer Element (TEE) and to provide a means for overexpression of gene products. The system exploits both transcriptional and translational approaches to control the expression levels of genes and/or gene products. Methods are also disclosed for screening libraries of random nucleotide sequences to identify translational elements and for overproduction of proteins, which have uses in both research and industrial environments.Type: GrantFiled: August 23, 2006Date of Patent: June 30, 2015Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Publication number: 20150152437Abstract: Provided herein are methods for stable integration and/or expression of one or more recombinant polynucleotides in a host cell. The recombinant polynucleotides are typically integrated into the host genome at some native chromosomal integration sites. The integration can be mediated by homologous recombination or by using a hybrid recombinase targeting the specific chromosomal locations. The native chromosomal integration sites in the host cells, which support stable integration and strong transcription activities of foreign genes, are present within or adjacent to specific genes in the CHO genome, ankyrin 2 gene (Ank2), cleavage and polyadenylation specific factor 4 gene (Cpsf4), C-Mos gene, and Nephrocystin-1/Mal gene. Also provided are methods and nucleic acid molecules for inserting site-specific recombination sequences (chromosomal landing pads) into these specific chromosomal locations.Type: ApplicationFiled: February 12, 2015Publication date: June 4, 2015Inventors: Vincent P. Mauro, Wei Zhou, Bruce Cunningham, Gerald M. Edelman
-
Patent number: 8980579Abstract: Provided herein are methods for stable integration and/or expression of one or more recombinant polynucleotides in a host cell. The recombinant polynucleotides are typically integrated into the host genome at some native chromosomal integration sites. The integration can be mediated by homologous recombination or by using a hybrid recombinase targeting the specific chromosomal locations. The native chromosomal integration sites in the host cells, which support stable integration and strong transcription activities of foreign genes, are present within or adjacent to specific genes in the CHO genome, the ankyrin 2 gene (Ank2), cleavage and polydenylation specific factor 4 gene (Cpsf4), C-Mos gene, and Nephrocystin-1/Mal gene. Also provided are methods and nucleic acid molecules for inserting site-specific recombination sequences (chromosomal landing pads) into these specific chromosomal locations, engineered host cells containing chromosomal landing pads, methods and compositions (e.g., kits) therefore.Type: GrantFiled: April 5, 2012Date of Patent: March 17, 2015Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Wei Zhou, Bruce Cunningham, Gerald M. Edelman
-
Publication number: 20140370545Abstract: Described herein are rules to modify natural mRNAs or to engineer synthetic mRNAs to increase their translation efficiencies. These rules describe modifications to mRNA coding and 3? UTR sequences intended to enhance protein synthesis by: 1) decreasing ribosomal diversion via AUG or non-canonical initiation codons in coding sequences, and/or 2) by evading miRNA-mediated down-regulation by eliminating one or more miRNA binding sites in coding sequences.Type: ApplicationFiled: September 4, 2014Publication date: December 18, 2014Inventors: Vincent P. Mauro, Stephen A. Chappell, Wei Zhou, Gerald M. Edelman
-
Patent number: 8853179Abstract: Described herein are rules to modify natural mRNAs or to engineer synthetic mRNAs to increase their translation efficiencies. These rules describe modifications to mRNA coding and 3? UTR sequences intended to enhance protein synthesis by: 1) decreasing ribosomal diversion via AUG or non-canonical initiation codons in coding sequences, and/or 2) by evading miRNA-mediated down-regulation by eliminating one or more miRNA binding sites in coding sequences.Type: GrantFiled: February 24, 2010Date of Patent: October 7, 2014Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Stephen A. Chappell, Wei Zhou, Gerald M. Edelman
-
Patent number: 8785611Abstract: Provided are mRNA translational enhancer elements (TEEs), e.g., SEQ ID NOs:1-35. Also provided are translational enhancer polynucleotides that comprise one or more of the specific TEEs exemplified herein or their variants, homologs or functional derivatives. Further provided are expression vectors comprising such TEEs or translational enhancer polynucleotides, as well as host cells and expression systems that harbor such vectors.Type: GrantFiled: December 11, 2008Date of Patent: July 22, 2014Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Publication number: 20130309682Abstract: Provided herein is a synthetic or isolated polynucleotide encoding a mammalian 18S rRNA that is resistant to pactamycin. The pactamycin-resistance is conferred by one or more single residue substitutions in the 18S rRNA sequence; a fragment thereof harboring said substitutions; a complementary sequence thereto; or a substantially identical sequence of the foregoing. Related systems, methods and kits are also described.Type: ApplicationFiled: May 21, 2013Publication date: November 21, 2013Inventors: Vincent P. Mauro, Luke Burman, Gerald M. Edelman
-
Patent number: 8350020Abstract: Provided are mRNA translational enhancer elements (TEEs), e.g., SEQ ID NOs:1-35. Also provided are translational enhancer polynucleotides that comprise one or more of the specific TEEs exemplified herein or their variants, homologs or functional derivatives. Further provided are expression vectors comprising such TEEs or translational enhancer polynucleotides, as well as host cells and expression systems that harbor such vectors.Type: GrantFiled: December 11, 2008Date of Patent: January 8, 2013Assignee: The Scripps Research InstituteInventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Publication number: 20120258541Abstract: Provided herein are methods for stable integration and/or expression of one or more recombinant polynucleotides in a host cell. The recombinant polynucleotides are typically integrated into the host genome at some native chromosomal integration sites. The integration can be mediated by homologous recombination or by using a hybrid recombinase targeting the specific chromosomal locations. The native chromosomal integration sites in the host cells, which support stable integration and strong transcription activities of foreign genes, are present within or adjacent to specific genes in the CHO genome, ankyrin 2 gene (Ank2), cleavage and polyadenylation specific factor 4 gene (Cpsf4), C-Mos gene, and Nephrocystin-1/Mal gene. Also provided are methods and nucleic acid molecules for inserting site-specific recombination sequences (chromosomal landing pads) into these specific chromosomal locations, engineered host cells containing chromosomal landing pads, methods and compositions (e.g., kits) therefore.Type: ApplicationFiled: April 5, 2012Publication date: October 11, 2012Inventors: Vincent P. Mauro, Wei Zhou, Bruce Cunningham, Gerald M. Edelman
-
Publication number: 20120053333Abstract: Described herein are rules to modify natural mRNAs or to engineer synthetic mRNAs to increase their translation efficiencies. These rules describe modifications to mRNA coding and 3? UTR sequences intended to enhance protein synthesis by: 1) decreasing ribosomal diversion via AUG or non-canonical initiation codons in coding sequences, and/or 2) by evading miRNA-mediated down-regulation by eliminating one or more miRNA binding sites in coding sequences.Type: ApplicationFiled: February 24, 2010Publication date: March 1, 2012Applicant: The Scripps Research InstitueInventors: Vincent P. Mauro, Stephen A. Chappell, Wei Zhou, Gerald M. Edelman
-
Publication number: 20110124100Abstract: A translation enhancer-driven positive feedback vector system is disclosed which is designed to facilitate identification of a Translational Enhancer Element (TEE) and to provide a means for overexpression of gene products. The system exploits both transcriptional and translational approaches to control the expression levels of genes and/or gene products. Methods are also disclosed for screening libraries of random nucleotide sequences to identify translational elements and for overproduction of proteins, which have uses in both research and industrial environments.Type: ApplicationFiled: August 16, 2010Publication date: May 26, 2011Applicant: The Scripps Research InstituteInventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou
-
Publication number: 20090226470Abstract: Provided are mRNA translational enhancer elements (TEEs), e.g., SEQ ID NOs:1-35. Also provided are translational enhancer polynucleotides that comprise one or more of the specific TEEs exemplified herein or their variants, homologs or functional derivatives. Further provided are expression vectors comprising such TEEs or translational enhancer polynucleotides, as well as host cells and expression systems that harbor such vectors.Type: ApplicationFiled: December 11, 2008Publication date: September 10, 2009Inventors: Vincent P. Mauro, Gerald M. Edelman, Wei Zhou